Natixis’s Briacell Therapeutics BCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-149
Closed -$130K 997
2023
Q4
$130K Sell
149
-488
-77% -$427K ﹤0.01% 734
2023
Q3
$597K Buy
637
+35
+6% +$32.8K ﹤0.01% 566
2023
Q2
$579K Buy
+602
New +$579K ﹤0.01% 605
2023
Q1
Sell
-83
Closed -$56.3K 978
2022
Q4
$56.3K Buy
+83
New +$56.3K ﹤0.01% 853